Literature DB >> 29217675

Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).

Tanya S Kenkre1, Pankaj Malhotra2, B Delia Johnson2, Eileen M Handberg2, Diane V Thompson2, Oscar C Marroquin2, William J Rogers2, Carl J Pepine2, C Noel Bairey Merz2, Sheryl F Kelsey2.   

Abstract

BACKGROUND: The WISE study (Women's Ischemia Syndrome Evaluation) was a prospective cohort study of 936 clinically stable symptomatic women who underwent coronary angiography to evaluate symptoms and signs of ischemia. Long-term mortality data for such women are limited. METHODS AND
RESULTS: Obstructive coronary artery disease (CAD) was defined as ≥50% stenosis on angiography by core laboratory. We conducted a National Death Index search to assess the mortality of women who were alive at their final WISE contact date. Death certificates were obtained. All deaths were adjudicated as cardiovascular or noncardiovascular by a panel of WISE cardiologists masked to angiographic data. Multivariate Cox proportional hazards regression was used to identify significant independent predictors of mortality. At baseline, mean age was 58±12 years; 176 (19%) were non-white, primarily black; 25% had a history of diabetes mellitus, 59% hypertension, 55% dyslipidemia, and 59% had a body mass index ≥30. During a median follow-up of 9.5 years (range, 0.2-11.5 years), a total of 184 (20%) died. Of these, 115 (62%) were cardiovascular deaths; 31% of all cardiovascular deaths occurred in women without obstructive CAD (<50% stenosis). Independent predictors of mortality were obstructive CAD, age, baseline systolic blood pressure, history of diabetes mellitus, history of smoking, elevated triglycerides, and estimated glomerular filtration rate.
CONCLUSIONS: Among women referred for coronary angiography for signs and symptoms of ischemia, 1 in 5 died from predominantly cardiac pathogeneses within 9 years of angiographic evaluation. A majority of the factors contributing to the risk of death seem to be modifiable by existing therapies. Of note, 1 in 3 of the deaths in this cohort occurred in women without obstructive CAD, a condition often considered benign and without guideline-recommended treatments. Clinical trials are needed to provide treatment guidance for the group without obstructive CAD.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  acute coronary syndrome; coronary artery disease; ischemia; mortality; women

Mesh:

Year:  2017        PMID: 29217675      PMCID: PMC5728666          DOI: 10.1161/CIRCOUTCOMES.116.003863

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  35 in total

1.  Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.

Authors:  Thomas M Maddox; P Michael Ho; Matthew Roe; David Dai; Thomas T Tsai; John S Rumsfeld
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-05

2.  Nonobstructive coronary artery disease and risk of myocardial infarction.

Authors:  Thomas M Maddox; Maggie A Stanislawski; Gary K Grunwald; Steven M Bradley; P Michael Ho; Thomas T Tsai; Manesh R Patel; Amneet Sandhu; Javier Valle; David J Magid; Benjamin Leon; Deepak L Bhatt; Stephan D Fihn; John S Rumsfeld
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

3.  Hypothetical ratings of coronary angiography appropriateness: are they associated with actual angiographic findings, mortality, and revascularisation rate? The ACRE study.

Authors:  H Hemingway; A M Crook; S Banerjee; J R Dawson; G Feder; P G Magee; A Wood; S Philpott; A Timmis
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

Review 4.  Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.

Authors:  Carl J Pepine; Keith C Ferdinand; Leslee J Shaw; Kelly Ann Light-McGroary; Rashmee U Shah; Martha Gulati; Claire Duvernoy; Mary Norine Walsh; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2015-10-27       Impact factor: 24.094

5.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.

Authors:  Lasse Jespersen; Anders Hvelplund; Steen Z Abildstrøm; Frants Pedersen; Søren Galatius; Jan K Madsen; Erik Jørgensen; Henning Kelbæk; Eva Prescott
Journal:  Eur Heart J       Date:  2011-09-11       Impact factor: 29.983

6.  Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women.

Authors:  A P Burke; A Farb; G T Malcom; Y Liang; J Smialek; R Virmani
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

7.  Sex differences in mortality following acute coronary syndromes.

Authors:  Jeffrey S Berger; Laine Elliott; Dianne Gallup; Matthew Roe; Christopher B Granger; Paul W Armstrong; R John Simes; Harvey D White; Frans Van de Werf; Eric J Topol; Judith S Hochman; L Kristin Newby; Robert A Harrington; Robert M Califf; Richard C Becker; Pamela S Douglas
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

8.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

9.  Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women.

Authors:  I Stensvold; A Tverdal; P Urdal; S Graff-Iversen
Journal:  BMJ       Date:  1993-11-20

10.  Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.

Authors:  Barry Sharaf; Todd Wood; Leslee Shaw; B Delia Johnson; Sheryl Kelsey; R David Anderson; Carl J Pepine; C Noel Bairey Merz
Journal:  Am Heart J       Date:  2013-05-02       Impact factor: 4.749

View more
  25 in total

1.  Cardiac pharmacologic stress: does the gender matters?

Authors:  Claudio Tinoco Mesquita; Wilter Dos Santos Ker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11       Impact factor: 9.236

Review 2.  Coronary Arterial Function and Disease in Women With No Obstructive Coronary Arteries.

Authors:  Harmony R Reynolds; C Noel Bairey Merz; Colin Berry; Rohit Samuel; Jacqueline Saw; Nathaniel R Smilowitz; Ana Carolina do A H de Souza; Robert Sykes; Viviany R Taqueti; Janet Wei
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

3.  Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.

Authors:  Jenifer M Brown; Wunan Zhou; Brittany Weber; Sanjay Divakaran; Leanne Barrett; Courtney F Bibbo; Jon Hainer; Viviany R Taqueti; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli
Journal:  Eur Heart J       Date:  2022-09-14       Impact factor: 35.855

Review 4.  Coronary microvascular dysfunction: Considerations for diagnosis and treatment.

Authors:  Benita Tjoe; Lili Barsky; Janet Wei; Bruce Samuels; Babak Azarbal; C Noel Bairey Merz; Chrisandra Shufelt
Journal:  Cleve Clin J Med       Date:  2021-10-01       Impact factor: 6.522

5.  Cold Pressor Testing and Sympathetic Nervous System Contribution to Ischemia with No Obstructive Coronary Artery Disease: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Project.

Authors:  J Wei; L L Barsky; S Jalnapurkar; P Zarrini; G Cook-Wiens; A AlBadri; M D Nelson; C Shufelt; B Sharif; D S Berman; Lej Thomson; E M Handberg; J W Petersen; R D Anderson; C J Pepine; C N Bairey Merz; P K Mehta
Journal:  Am Heart J Plus       Date:  2021-12-28

Review 6.  Sex differences in heart failure.

Authors:  Evann Eisenberg; Katherine E Di Palo; Ileana L Piña
Journal:  Clin Cardiol       Date:  2018-02-27       Impact factor: 2.882

Review 7.  Coronary Microvascular Angina: A State-of-the-Art Review.

Authors:  Francesco Spione; Victor Arevalos; Rami Gabani; Manel Sabaté; Salvatore Brugaletta
Journal:  Front Cardiovasc Med       Date:  2022-03-30

Review 8.  Coronary Microvascular Dysfunction in Patients With Systemic Lupus Erythematosus and Chest Pain.

Authors:  Ashley S Manchanda; Alan C Kwan; Mariko Ishimori; Louise E J Thomson; Debiao Li; Daniel S Berman; C Noel Bairey Merz; Caroline Jefferies; Janet Wei
Journal:  Front Cardiovasc Med       Date:  2022-04-15

Review 9.  Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation.

Authors:  Lili Barsky; C Noel Bairey Merz; Janet Wei; Chrisandra Shufelt; Eileen Handberg; Carl Pepine; Thomas Rutledge; Steven Reis; Mark Doyle; William Rogers; Leslee Shaw; George Sopko
Journal:  Curr Atheroscler Rep       Date:  2020-06-18       Impact factor: 5.967

10.  Gelatin Methacryloyl Bioadhesive Improves Survival and Reduces Scar Burden in a Mouse Model of Myocardial Infarction.

Authors:  Leon M Ptaszek; Roberto Portillo Lara; Ehsan Shirzaei Sani; Chunyang Xiao; Jason Roh; Xuejing Yu; Pablo A Ledesma; Chu Hsiang Yu; Nasim Annabi; Jeremy N Ruskin
Journal:  J Am Heart Assoc       Date:  2020-05-27       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.